검색어 : 통합검색[Mosley Walter]
총 107건 중 107건 출력
, 10/11 페이지
-
91
- Patterns of Factors in the NIA Health Disparities Research Framework Domains and Mild Cognitive Impairment Risk
- Maria Vassilaki; Jeremiah A. Aakre; Timothy G. Lesnick; Walter K. Kremers; Jonathan Graff-Radford; David S. Knopman; Thomas H. Mosley; B. Gwen Windham; Michael E. Griswold; Yonas E. Geda; Val J. Lowe; Clifford R. Jack; Ronald C. Petersen; Prashanthi Vemuri; ; (AJPM Focus, v., 2025, pp.100324-100324)
-
92
- Patterns in NIA Health Disparities Research Framework Domains and AD‐Plasma Biomarkers
- Maria Vassilaki; Jeremiah A Aakre; Anna M Castillo; Timothy G. Lesnick; Walter K. Kremers; Alicia Algeciras‐Schimnich; Jonathan Graff‐Radford; David S. Knopman; Thomas H. Mosley; B Gwen Windham; Michael E. Griswold; Val J. Lowe; Clifford R. Jack; Ronald C. Petersen; Prashanthi Vemuri; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Quantitative Health Sciences, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Department of Neurology, Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; University of Mississippi Medical Center, Jackson, MS USA; Department of Medicine/Geriatrics, The Memory Impairment and Neurodegenerative Dementia (MIND) Center, University of Mississippi Medical Center, Jackson, MS USA; University of Mississippi Medical Center, The MIND Center, Jackson, MS USA; Department of Radiology, Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; (Alzheimer's & Dementia, v., 2024, )
-
93
- Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics
- Charrier, N.; Clarke, B.; Cutler, L.; Demont, E.; Dingwall, C.; Dunsdon, R.; Hawkins, J.; Howes, C.; Hubbard, J.; Hussain, I.; Maile, G.; Matico, R.; Mosley, J.; Naylor, A.; O'Brien, A.; Redshaw, S.; Rowland, P.; Soleil, V.; Smith, K.J.; Sweitzer, S.; Theobald, P.; Vesey, D.; Walter, D.S.; Wayne, G.; Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; ine R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; (Bioorganic & medicinal chemistry letters, v.19, 2009, pp.3664-3668)
-
94
- Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics
- Charrier, N.; Clarke, B.; Cutler, L.; Demont, E.; Dingwall, C.; Dunsdon, R.; Hawkins, J.; Howes, C.; Hubbard, J.; Hussain, I.; Maile, G.; Matico, R.; Mosley, J.; Naylor, A.; O'Brien, A.; Redshaw, S.; Rowland, P.; Soleil, V.; Smith, K.J.; Sweitzer, S.; Theobald, P.; Vesey, D.; Walter, D.S.; Wayne, G.; Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; ine R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; (Bioorganic & medicinal chemistry letters, v.19, 2009, pp.3674-3678)
-
95
- Patterns in NIA Health Disparities Research Framework Domains and AD‐Plasma Biomarkers
- Vassilaki, Maria; Aakre, Jeremiah A; Castillo, Anna M; Lesnick, Timothy G.; Kremers, Walter K.; Algeciras‐ Schimnich, Alicia; Graff‐ Radford, Jonathan; Knopman, David S.; Mosley, Thomas H.; Windham, B Gwen; Griswold, Michael E.; Lowe, Val J.; Jack Jr., Clifford R.; Petersen, Ronald C.; Vemuri, Prashanthi; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Quantitative Health Sciences, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Department of Neurology, Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; University of Mississippi Medical Center, Jackson, MS USA; Department of Medicine/Geriatrics, The Memory Impairment and Neurodegenerative Dementia (MIND) Center, University of Mississippi Medical Center, Jackson, MS USA; University of Mississippi Medical Center, The MIND Center, Jackson, MS USA; Department of Radiology, Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; Mayo Clinic, Rochester, MN USA; (Alzheimer's & dementia : the journal of the Alzheimer's Association, v.20, 2024, pp.e095372)
-
96
- Second Generation of Hydroxyethylamine BACE-1 Inhibitors: Optimizing Potency and Oral Bioavailability
- Charrier, Nicolas; Clarke, Brian; Cutler, Leanne; Demont, Emmanuel; Dingwall, Colin; Dunsdon, Rachel; East, Philip; Hawkins, Julie; Howes, Colin; Hussain, Ishrut; Jeffrey, Phil; Maile, Graham; Matico, Rosalie; Mosley, Julie; Naylor, Alan; O’Brien, Alistair; Redshaw, Sally; Rowland, Paul; Soleil, Virginie; Smith, Kathrine J.; Sweitzer, Sharon; Theobald, Pam; Vesey, David; Walter, Daryl S.; Wayne, Gareth; ; (Journal of medicinal chemistry, v.51, 2008, pp.3313-3317)
-
97
- BACE-1 inhibitors Part 1: Identification of novel hydroxy ethylamines (HEAs)
- Clarke, B.; Demont, E.; Dingwall, C.; Dunsdon, R.; Faller, A.; Hawkins, J.; Hussain, I.; MacPherson, D.; Maile, G.; Matico, R.; Milner, P.; Mosley, J.; Naylor, A.; O'Brien, A.; Redshaw, S.; Riddell, D.; Rowland, P.; Soleil, V.; Smith, K.J.; Stanway, S.; Stemp, G.; Sweitzer, S.; Theobald, P.; Vesey, D.; Walter, D.S.; Ward, J.; Wayne, G.; Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; ine R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; (Bioorganic & medicinal chemistry letters, v.18, 2008, pp.1011-1016)
-
98
- BACE-1 inhibitors part 2: Identification of hydroxy ethylamines (HEAs) with reduced peptidic character
- Clarke, B.; Demont, E.; Dingwall, C.; Dunsdon, R.; Faller, A.; Hawkins, J.; Hussain, I.; MacPherson, D.; Maile, G.; Matico, R.; Milner, P.; Mosley, J.; Naylor, A.; O'Brien, A.; Redshaw, S.; Riddell, D.; Rowland, P.; Soleil, V.; Smith, K.J.; Stanway, S.; Stemp, G.; Sweitzer, S.; Theobald, P.; Vesey, D.; Walter, D.S.; Ward, J.; Wayne, G.; Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; ine R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, United Kingdom; (Bioorganic & medicinal chemistry letters, v.18, 2008, pp.1017-1021)
-
99
- BACE-1 hydroxyethylamine inhibitors using novel edge-to-face interaction with Arg-296
- Clarke, Brian; Cutler, Leanne; Demont, Emmanuel; Dingwall, Colin; Dunsdon, Rachel; Hawkins, Julie; Howes, Colin; Hussain, Ishrut; Maile, Graham; Matico, Rosalie; Mosley, Julie; Naylor, Alan; O’ Brien, Alistair; Redshaw, Sally; Rowland, Paul; Soleil, Virginie; Smith, Kathrine J.; Sweitzer, Sharon; Theobald, Pam; Vesey, David; Walter, Daryl S.; Wayne, Gareth; ; (Bioorganic & medicinal chemistry letters, v.20, 2010, pp.4639-4644)
-
100
- BACE-1 inhibitors part 3: Identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells
- Beswick, P.; Charrier, N.; Clarke, B.; Demont, E.; Dingwall, C.; Dunsdon, R.; Faller, A.; Gleave, R.; Hawkins, J.; Hussain, I.; Johnson, C.N.; MacPherson, D.; Maile, G.; Matico, R.; Milner, P.; Mosley, J.; Naylor, A.; O'Brien, A.; Redshaw, S.; Riddell, D.; Rowland, P.; Skidmore, J.; Soleil, V.; Smith, K.J.; Stanway, S.; Stemp, G.; Stuart, A.; Sweitzer, S.; Theobald, P.; Vesey, D.; Walter, D.S.; Ward, J.; Wayne, G.; Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK; ine R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK; (Bioorganic & medicinal chemistry letters, v.18, 2008, pp.1022-1026)
QUICK MENU
